Bristol-Myers Squibb Q3 Adj. EPS $2.00 Beats $1.76 Estimate, Sales $10.97B Miss $10.97B Estimate
Portfolio Pulse from Benzinga Newsdesk
Bristol-Myers Squibb reported Q3 earnings of $2.00 per share, beating the analyst consensus estimate of $1.76 by 13.64%. However, the company's quarterly sales of $10.97 billion missed the analyst consensus estimate of $10.97 billion by 0.04%, marking a 2.25% decrease from the same period last year.
October 26, 2023 | 11:00 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Bristol-Myers Squibb's Q3 earnings beat estimates but sales missed, which could lead to mixed market reactions.
Bristol-Myers Squibb's Q3 earnings beat analyst estimates, which is positive for the stock. However, the company's sales missed estimates, which is negative. These two factors could offset each other, leading to a neutral short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100